Please check back for upcoming events!
Glutamine and Sickle Cell Anemia
Yutaka Niihara, MD, MPH, chief scientific officer and founder of Emmaus Life Sciences talks about their orphan designated drug L-glutamine to treat patients with sickle cell anemia.
Angela G. King
October 17, 2016
One of the most common genetic disruptions to blood flow in the human body that exists, Sickle Cell Disease afflicts millions of men, women and children around the globe - up to 100,000 of them living in the United States. Yet a universal cure, or even slate of treatments to effectively combat its often painful and debilitating, at times fatal symptoms remain elusive. That could finally be about to change substantively. In her three-part series, she presents stories that explores this prospect among a community still languishing so far beneath the radar of public consciousness.
Couple's attempt to do the
right thing brings more grief
Los Angeles Times
March 11, 2009
Read the article...